Insider trades
Kenneth T. Mills, Director of Regenxbio RGNX, has filed 0 purchases and 12 sales on the open market. The latest trade was on 05/29.
Kenneth T. Mills
Director
- Company
- Regenxbio RGNX
- First filing
- 23/01/05
- Trades
- 53 trades
- Buys / sales
- 0 / 12
- 12-month net buying
- No record
- Last trade
- 05/29
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RegenxbioRGNX | Open-market sale10b5-1 plan | 25/05/12 | 25/05/14 | 20,602 sh | $7.91 | $162,961.82 | −4.2% |
RGNX | Open-market sale10b5-1 plan | 24/07/24–24/07/25 | 24/07/26 | 27,590 sh2 trades | $13.88avg. | $382,956.62 | −6.3% |
RGNX | Open-market sale10b5-1 plan | 24/07/16–24/07/17 | 24/07/18 | 2,410 sh2 trades | $13.77avg. | $33,183.7 | −0.6% |
RegenxbioRGNX | Open-market sale10b5-1 plan | 24/05/14 | 24/05/16 | 15,000 sh | $15.81 | $237,150 | −3.5% |
RegenxbioRGNX | Open-market sale10b5-1 plan | 24/04/15 | 24/04/17 | 15,000 sh | $18.19 | $272,850 | −3.5% |
RegenxbioRGNX | Open-market sale10b5-1 plan | 24/03/14 | 24/03/18 | 15,000 sh | $21.86 | $327,900 | −3.5% |
RGNX | Open-market sale10b5-1 plan | 24/02/14 | 24/02/16 | 15,000 sh2 trades | $16.75avg. | $251,292.68 | −3.5% |
RegenxbioRGNX | Open-market sale10b5-1 plan | 24/01/16 | 24/01/18 | 45,000 sh | $15.18 | $683,100 | −9.9% |
RegenxbioRGNX | Open-market sale10b5-1 plan | 23/12/19 | 23/12/21 | 45,000 sh | $19.69 | $886,050 | −11.2% |